← Latest Filings
R

Roivant Sciences Ltd.

Open-market buys
1
$350.0M total
Open-market sells
0
$0 total
Tracking since
Dec 2025
Open-market buy — $350.0M
Immunovant, Inc. · Dec 12, 2025
Open-market trades from the last two years.
113,317,007 Common Stock, $0.0001 par value per share in IMVT
Held directly · as of 2025-12-12
29,880,079 Common Shares in ABUS
Held directly · as of 2026-10-01
Arbutus Biopharma Corp
CIK 0001447028
Immunovant, Inc.
CIK 0001764013